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Sortilin Is Expressed in Cultured Human
Keratinocytes and Is Regulated by Cutaneous
Neuropeptides
Ma´ria Kiss1, Attila Dallos2, Bernadett Kormos1, Petra Sa´ntha1, Attila Dobozy1,2, Sa´ndor Husz1 and
Lajos Keme´ny1,2
Sortilin, a member of the family of Vps10p domain receptors, has been shown to be able to bind the precursor
peptide of nerve growth factor (proNGF). ProNGF interacts with sortilin and the p75NTR receptor on the cell
surface to form a molecular complex capable of activating an apoptotic cascade. Keratinocytes can secrete
proNGF and they have p75NTR on their surface. The expression of sortilin in normal human keratinocytes has
not yet been clearly shown. In this study, we show that keratinocytes express sortilin mRNA, and the presence
of sortilin protein is shown in cultured keratinocytes and in normal human skin. We have also shown that the
cutaneous neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide, and
galanin are able to reduce the expression of sortilin mRNA and sortilin protein in cultured human keratinocytes.
In addition, each of the analyzed neuropeptides has the ability to arrest the proNGF-induced apoptosis of
human keratinocytes. These results suggest that all the participants in the NGF/proNGF pathway are present in
the keratinocytes, and cutaneous neuropeptides can modulate their expressions and actions. The NGF/proNGF
balance and its regulation by neuropeptides may have an important role in skin homeostasis.
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INTRODUCTION
Sortilin, a 95 kDa glycoprotein, is a member of the recently
discovered mammalian Vps10p domain-containing trans-
membrane receptor family. This domain was named after the
yeast-sorting protein Vps10p (Marcusson et al., 1994). In
sortilin, the domain comprises the entire N-terminal luminal/
extracellular part of the receptor and the receptor contains a
short cytoplasmic domain that furnishes typical motifs for
interactions with cytosolic adapter molecules. Sortilin is
mainly expressed in the neurons of the central nervous system
(Hermans-Borgmeyer et al., 1999; Domeniconi et al., 2007).
Besides being present in the brain, sortilin is abundant in
diverse cell types, including the spinal cord, skeletal muscle,
testis, heart, adipocytes, and melanocytes (Morris et al.,
1998; Hassan et al., 2004; Truzzi et al., 2008; Hermey,
2009). The experimental data indicate that sortilin, acting as
an endocytic and intracellular sorting receptor, contributes to
the targeting of ligands to lysosomes and the sorting between
the Golgi apparatus and endosomes (Lefrancois et al., 2003;
Canuel et al., 2008; Mari et al., 2008). However, sortilin has
also been shown to serve additional cell- and tissue-specific
functions. There is appreciable evidence of its expression on
the cell surface (Nielsen et al., 1999; Navarro et al., 2001).
Accordingly, sortilin not only serves as a general intracellular
sorting receptor, but also mediates specialized functions, for
instance as a co-receptor determining the neurotrophin
signaling pathway (Nykjaer et al., 2004; Hermey, 2009).
The nerve growth factor (NGF) is a polypeptide that
belongs in the neurotrophin family. NGF binds to two classes
of transmembrane receptors: a tyrosine kinase receptor of
140 kDa (TrkA) (Kaplan et al., 1991) and a glycoprotein
receptor of 75 kDa (p75NTR) (Dechant and Barde, 1997). In
neuronal cells, NGF binds to TrkA, and dimerization and
autophosphorylation of the receptor occur, promoting
survival and differentiation (Segal, 2003). By contrast,
p75NTR can induce apoptosis through its own signal
transduction (Wang et al., 2001). NGF is synthesized as
precursor NGF (proNGF) and processed posttranslationally
into mature NGF by an enzymatic cleavage (Kliemannel
et al., 2004). Sortilin has been shown to be able to bind
proNGF (Nykjaer et al., 2004) and proNGF is a high-affinity
ligand for p75NTR. There is experimental and computational
evidence that proNGF interacts through its pro-domain with
sortilin, while the mature domain of NGF can interact with
p75NTR (Paiardini and Caputo, 2008). Thus, sortilin can itself
bind both precursors, and the formation of a complex with
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p75NTR leads to extended affinity for proNGF. The p75NTR-
sortilin complex couples with proNGF to induce apoptosis
(Kaplan and Miller, 2004; Schweigreiter, 2006).
NGF has been shown to have a major role in skin
homeostasis and inflammatory skin diseases. It has several
regulatory functions in cutaneous nociception, nerve deve-
lopment, and regeneration (Pincelli and Yaar, 1997; Stander
et al., 2009). In the skin, NGF is expressed mostly by
keratinocytes (Tron et al., 1990). NGF in cutaneous
keratinocytes has been suggested to be a key player in an
autocrine loop, acting as mitogen, and survival factor through
its high-affinity receptor TrkA (Pincelli and Marconi, 2000).
In keratinocytes, NGF production is influenced by neuro-
peptide release.
The human skin is abundantly supplied with sensory
nerves, which form part of the peripheral nervous system
(Reilly et al., 1997). This rich network of free sensory nerve
endings surrounds and penetrates hair follicles, eccrine, and
apocrine glands, the papillary dermis and the epidermis
(Hilliges et al., 1995). Both under normal conditions and
under pathological conditions, various neuropeptides are
released from these free nerve endings (Scholzen et al.,
1998). Moreover, keratinocytes possess several receptors for
these neuropeptides (Takahashi et al., 1993; Kemeny et al.,
1994; Lotti et al., 1995; Dallos et al., 2006b; Chang et al.,
2007). We earlier showed that the cutaneous neuropeptides
substance P (SP), calcitonin gene-related peptide (CGRP),
vasoactive intestinal polypeptide (VIP), and galanin (GAL) are
able to increase the mRNA expression of NGF in cultured
human keratinocytes and to enhance NGF secretion (Dallos
et al., 2006a). The secretion of proNGF by keratinocytes
into the intercellular space has also been shown to occur
(Dallos et al., 2006a). In the epidermal milieu, all the
participants in the NGF/proNGF signaling pathway are
present except sortilin. To date, the presence of sortilin in
the human keratinocytes or in normal human skin has not
been clearly shown. However, there is significant evidence of
the presence of p75NTR in these cells (Dechant and Barde,
1997; Okumura et al., 2003; Peters et al., 2007) and its role in
the apoptosis of the keratinocytes can be hypothesized.
This study was performed to determine the presence of
sortilin in cultured human keratinocytes and in human skin,
with regard to mRNA and protein levels. In addition, we
studied the effects of SP, CGRP, VIP, and GAL on the
expression of sortilin mRNA and protein and on proNGF-
induced apoptosis in cultured human keratinocytes.
RESULTS
Identification of sortilin mRNA and sortilin protein
in cultured human keratinocytes
In the first step, we analyzed the presence of sortilin at the
level of mRNA. Using the Human Sortilin TaqMan Gene
Expression Assay and the human keratinocyte template, we
succeeded in detecting an amplified product with the
expected molecular size. With human brain complementary
DNA as a positive control instead of the keratinocyte
template, we detected the amplified product with the same
molecular size (Figure 1a). Next, we performed western
blotting assays on cultured human keratinocyte extracts to
detect sortilin protein, with human brain protein extract as
a positive control. With both the human keratinocyte and
the human brain extracts, we were able to show the sortilin
protein with the expected molecular weight of 95 kDa
(Figure 1b). Preabsorption assays were carried out to verify
the specificity of the sortilin antibody. Using blocking peptide
preabsorbed with sortilin antibody, we did not observe a
signal for either the keratinocyte extract or the human brain
extract (data not shown).
Immunocytochemical investigation of the expression
of sortilin in cultured human keratinocytes
In the next step, immunocytochemical investigations were
performed on cultured human keratinocytes. Immunocyto-
chemical assays on cultured human keratinocytes with the
use of polyclonal anti-sortilin antibody revealed considerable
immune staining both in the cytoplasm and on the surface
of the cells (Figure 2b and c). The distribution of immune
staining proved to be cytoplasmic, but in certain areas the
surfaces of the cells were also stained. Specific immune
staining was not found on the isotype control (Figure 2a).
In situ expression of sortilin in human skin
On skin samples from five persons undergoing plastic
surgery, we carried out immunohistochemical investigations
to show the presence of sortilin in the different layers of the
human skin, and to examine how the level of intensity varies.
With polyclonal anti-sortilin antibody, the highest sortilin
expression was found in the basal layer of the epidermis,
while in the spinous layer there was only faint staining, and
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Figure 1. Expressions of sortilin mRNA and protein in cultured human
keratinocytes. Reverse transcription (RT)-PCR was carried out on mRNA
derived from human keratinocytes and human brain extract to show the
presence of sortilin mRNA. The 129-bp PCR product of sortilin was detected
with the use of either keratinocyte complementary DNA (cDNA) or human
brain cDNA (a; KC¼ human keratinocytes, B¼ human brain). The presence
of sortilin protein was detected by using western blotting in protein extracts
from cultured human keratinocytes and human brain. (b) Shows the presence
of sortilin protein with the expected molecular weight (95 kDa) in the
lysates from both human keratinocytes and human brain. Absorption control
experiments were performed with the sortilin blocking peptide to test the
specificity of the primary antibody (data not shown).
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the granular layer also showed moderate sortilin positivity
(Figure 3b and c). In the isotype control, there was no specific
staining at all (Figure 3a). Some sortilin-positive cells were
also found in the dermis.
Influence of neuropeptides (SP, CGRP, VIP, or GAL) on the
expressions of sortilin mRNA and sortilin protein in cultured
human keratinocytes
After the induction of subconfluent cultured keratinocytes
with SP (108 M), significant decreases of approximately
40–50% were experienced in the amounts of sortilin mRNA
as compared with the time-matched controls at 3 and 6 hours
after the treatment (Figure 4a). Investigation of sortilin protein
revealed an increase at 24 hours in the neuropeptide-treated
cells, but the difference was not significant. Later, the amount
of sortilin protein gradually decreased, and after 72 hours in
the SP-treated cultures the decrease (60%) was significant
relative to the controls (Figure 4b).
After the induction of keratinocyte cultures with CGRP
(108M), there was no significant difference in the expression of
sortilin mRNA (Figure 4c). Interestingly, the sortilin protein
levels in the CGRP-treated cultures were dramatically decreased
(60 and 70%) at 48 and 72hours after the treatment (Figure 4d).
The induction of cultured keratinocytes with VIP (108 M)
resulted in a significant decrease (70%) in the expression of
sortilin mRNA at 6 hours after the treatment. Later, at 12 and
24 hours, the sortilin mRNA expression in the VIP-treated
samples had reached the same levels as in the controls
(Figure 4e). The amount of sortilin protein in the VIP-treated
cultures showed a slight, but significant decrease (30%) only
72 hours after the treatment (Figure 4f).
The effects of GAL (108 M) on the expression of sortilin
mRNA of cultured keratinocytes were noteworthy at 6 and
12 hours after the treatment, when 80% decreases in sortilin
mRNA expression were shown (Figure 4g). A significant
decrease (50%) in sortilin protein level was detected at
72 hours after the neuropeptide treatment (Figure 4h).
Neuropeptides modulate the proNGF-induced apoptosis in
cultured human keratinocytes
Normal human keratinocytes were cultured in keratinocyte
serum-free medium in 96-well plates. After 24 hours, the cells
were induced with proNGF (100 ngml–1) alone, or together
with the combinations of proNGF and SP, or CGRP, or VIP, or
GAL. After 48 hours, the extent of apoptosis was detected by
using an in situ apoptosis detection kit. The cell cultures
treated with only proNGF showed a considerable increase in
apoptotic cell index (1.4) as compared with the untreated
cultures (1.0). In each of the keratinocyte cultures treated
with proNGF supplemented with one or other of the
a b c
Figure 2. Immunocytochemical analysis of sortilin in cultured human keratinocytes. Cultured normal human keratinocytes (derived from adult human
breast skin) were subjected to immunocytochemical studies to analyze the expression of sortilin. No specific staining was found for the negative
control (a). (b, c) Illustrate the immune staining of the sortilin in the cytoplasm and on the surface of the keratinocytes at various magnifications.
Nuclei were counterstained with hematoxylin. Scale bar¼ 50mm (a–c).
a b c
Figure 3. Localization of sortilin in the different layers of normal human skin by immunohistochemistry. The figure shows the expression of sortilin
in normal human female breast skin obtained from a patient undergoing plastic surgery. A negative control was performed with normal rabbit IgG instead
of primary antibody (a). (b, c) Show the more intensive coloration of the basal keratinocytes (black arrow), but immunostaining was additionally detected
in the other layers of the epidermis. Positive blood vessel cells and lymphoid elements (red arrow) can also be observed in the dermis. Nuclei were
counterstained with hematoxylin. Section thickness: 4mm. Scale bar¼ 50mm (a–c).
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neuropeptides, a significant decrease was shown in the
apoptotic index relative to the cells induced with proNGF
alone (0.7–0.9 vs 1.4) (Figure 5a). To reconfirm the results, an
Annexin V apoptosis assay was also carried out by the above-
detailed method; this indicated a similar tendency of the
proNGF-induced apoptosis (Figure 5b).
DISCUSSION
Sortilin is expressed in cultured human keratinocytes and in
normal skin
To date, the expression of sortilin in human keratinocytes or
in human skin has not been clearly shown. Our study
revealed the presence of sortilin at both the mRNA and
protein levels in cultured human keratinocytes. Immunocy-
tochemical investigations showed that the expression of
sortilin in the keratinocytes is mostly cytoplasmic, and some
cells show sortilin-specific cell surface staining. In normal
human skin, the highest sortilin expression was found in the
basal layer of the epidermis, but moderate or slight sortilin
positivity was also observed in the upper dermis. A majority
of the cells showed cytoplasmic staining, but cell-surface
sortilin expression was additionally detected on the kerati-
nocytes of the epidermal basal layer.
Sortilin is expressed in diverse cell types, the highest
amount of sortilin being found in the vesicles within the cells
(Lin et al., 1997). However, several studies have revealed the
presence of sortilin on the surface of various cells (Nielsen
et al., 1999; Navarro et al., 2001); its expression on the
surface of human keratinocytes may be of considerable
biological significance. It is well documented that, in
neuronal cells, the NGF pathway (neurotrophin pathway)
has a central role in the maintenance of the balance between
neuronal cell proliferation, differentiation, and apoptosis
(Nykjaer et al., 2004). NGF and its precursor proNGF are
very important in this process. ProNGF elicits opposite
biological effects to those of mature NGF; while mature
NGF promotes cell survival and cell proliferation, proNGF
can cause cell death (Ibanez, 2002). These opposite effects
are mediated by the interactions with different transmem-
brane signaling systems. The TrkA receptor preferentially
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Figure 4. The effects of cutaneous neuropeptides on the expressions of sortilin mRNA and sortilin protein in cultured human keratinocytes. Cultured human
keratinocytes were treated with SP, CGRP, VIP, or GAL at 108 M for 30minutes. (a) Depicts the changes in sortilin mRNA expression after treatment
with SP, relative to the untreated time-matched controls. The changes in the relative amount of sortilin protein in the lysate from human keratinocytes after
SP induction are observed in (b). (c, d) Present the sortilin mRNA and protein changes caused by CGRP, (e, f) caused by VIP, and (g, h) caused by GAL.
The reported data were calculated as the means±SD of the results of three independent experiments. **Po0.01;’, control;&, neuropeptide-treated samples.
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binds mature NGF, while a receptor complex sortilin–p75NTR
interacts with proNGF to activate the proNGF-mediated cell
death signaling pathway (Lee et al., 2001; Nykjaer et al.,
2004, 2005). This NGF pathway has been shown to operate
in neuronal cells (Nykjaer et al., 2004; Volosin et al., 2006)
and has been hypothesized in some other tissues (Peters
et al., 2006), but it is as yet unknown in keratinocytes.
It is obvious that NGF is a very important and potent
growth factor in the skin. Normal human keratinocytes
synthesize and release high amounts of biologically active
NGF. In addition, human keratinocytes express both the high-
affinity (TrkA) and the low-affinity (p75NTR) receptors (Pincelli
et al., 1994). NGF is the key component of an autocrine loop,
acting as a mitogen and as a survival factor for human
keratinocytes (Di Marco et al., 1993; Pincelli and Yaar,
1997). Moreover, NGF is a crucial neurotrophin molecule for
skin innervation (Albers et al., 1994). Besides mature,
biologically active NGF, proNGF is also produced and
secreted by cultured human keratinocytes (Dallos et al.,
2006a). We have now shown that keratinocytes can express
sortilin, which seems to be essential for the proNGF-induced
apoptotic process. All the participants in the NGF pathway
are therefore present in the epidermal milieu and can
operate. We have also established that proNGF is able to
induce apoptosis in cultured human keratinocytes, which is
indirect evidence that the NGF/proNGF balance exists and
may be important in skin homeostasis. This idea is supported
by the fact that the production of mature NGF is increased in
inflammatory skin conditions such as psoriasis accompanied
by keratinocyte hyperproliferation (Pincelli and Marconi,
2000; Raychaudhuri and Raychaudhuri, 2004). Even less is
known regarding the NGF receptor expression. In some
studies on psoriasis, TrkA and p75NTR were found to be
upregulated, while in other studies the opposite was the case
(Bull et al., 1998). It was recently reported that the p75NTR
level is significantly lower in psoriatic than in normal
keratinocytes, and p75NTR protein seems to be absent in
psoriatic lesional skin. These results indicate that p75NTR acts
as a pro-apoptotic receptor in human keratinocytes and the
decrease or absence of p75NTR receptors in psoriasis could
account for the resistance of psoriatic keratinocytes to
apoptosis (Truzzi et al., 2006; Marconi et al., 2008).
Cutaneous neuropeptides modulate sortilin expression and
proNGF-induced apoptosis in cultured human keratinocytes
In the second part of our study, we examined the effect of the
neuropeptides SP, CGRP, VIP, and GAL on the expression of
sortilin by cultured human keratinocytes and on the proNGF-
induced apoptosis of cultured keratinocytes. Under both
normal and pathological conditions, various neuropeptides
are released from free nerve endings. The secreted neuropep-
tides can interact with keratinocytes to modulate their
function. One of the well-known characteristics of SP, CGRP,
and VIP is their ability to promote the proliferation of
keratinocytes (Haegerstrand et al., 1989; Takahashi et al.,
1993; Benrath et al., 1995), i.e., they promote the survival of
cells rather than cause their apoptosis. Currently, little
knowledge is available on the effects of GAL on human
keratinocytes. In neural cells, GAL may exert a proliferative
effect (Wang et al., 1998). SP, CGRP, VIP, and GAL are
known to increase the production and secretion of mature
NGF to different extents in cultured human keratinocytes
(Dallos et al., 2006a); and the keratinocytes produce and
secrete proNGF. As neuropeptides can modulate the NGF
production of keratinocytes, it seemed reasonable to analyze
the effects of these neuropeptides on the sortilin expression of
keratinocytes. Sortilin with p75NTR represents the opposite
arm of the NGF/proNGF neurotrophin pathway.
Throughout the study, we used a constant concentration of
stimulating neuropeptide, 108 M. We took into consideration
the concentrations reported for each neuropeptide to occur
physiologically in the serum (Koch et al., 1991; Schifter,
1991; Bondy et al., 2003). We included relatively high
concentrations of stimulating peptides because serum con-
centrations of growth factors, hormones, and neuropeptides
not necessarily reflect the concentrations in the direct
pericellular microenvironment, which do can exceed serum
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Figure 5. The neuropeptides SP, CGRP, VIP, and GAL modulate the proNGF-
induced apoptosis in cultured human keratinocytes. Apoptosis in human
keratinocytes was detected by using an in situ apoptosis detection kit on the
basis of the measurement of DNA fragmentation (a) and by using the Annexin
V apoptosis assay (b). Human keratinocytes were induced with proNGF
(100 ngml–1) alone or together with the combinations of proNGF and SP,
CGRP, VIP, or GAL. The reported data were calculated as the means±SD
of the results on at least triplicate wells of three independent experiments
(*Po0.05; **Po0.01) (a). The results (b) are expressed as the means of
two independent experiments (&, control; ’, proNGF, or
proNGFþ neuropeptide-treated cultures).
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levels. The findings of our previously published experiments
and the other studies led us to choose 108 M as the constant
concentration of the stimulating peptide (Kiss et al., 1999;
Burbach et al., 2001; Brenneman et al., 2003; Dallos et al.,
2006a).
Evidence emerged that each of the analyzed neuropep-
tides was able to reduce both sortilin mRNA and protein
expression in cultured human keratinocytes. However, there
were some discrepancies between the timing of the sortilin
mRNA decrease and the protein decrease brought about by
the neuropeptides. Although the sortilin mRNA expression
was decreased significantly relative to the untreated controls
6–12 hours after neuropeptide treatment, the decrease in
sortilin protein content could be shown only after
48–72 hours. Our mRNA measurements were normalized
for 18S ribosomal RNA as housekeeping gene; there were no
significant differences in 18S ribosomal RNA expression
between neuropeptide-treated samples and their time-
matched controls (data not shown). There must obviously
be some explanation for the apparently contradictory sortilin
mRNA and protein data. The half-life of sortilin is not yet
known, but it is possible that sortilin protein has a relatively
long lifetime, which might explain why we experienced
a sortilin protein decrease only 48–72 hours after the neuro-
eptide treatment.
We earlier showed that human keratinocytes can secrete
proNGF (Dallos et al., 2006a). Accordingly, to study the
functionality of sortilin as a coreceptor, we induced cultured
keratinocytes with proNGF and measured the apoptotic index
in the cultures. There are merely a few studies in the literature
regarding proNGF-induced apoptosis. The concentration of
proNGF in different apoptosis assays varied in the range
2–300 ngml–1, depending on the experimental system
(Nykjaer et al., 2004; Althaus and Klo¨ppner, 2006). In our
preliminary experiments, we used 20, 100, and 500ngml–1
proNGF for keratinocyte apoptosis induction and, on the
basis of our results, we finally chose 100 ngml–1 proNGF. In
agreement with our hypothesis that the presence of sortilin on
keratinocytes may facilitate a pro-apoptotic process, there
was a considerable increase in the apoptotic index of the
proNGF-induced cells as compared with that of the untreated
cells. This accords well with our findings, as each of the
analyzed neuropeptides was able to reduce the amounts of
both sortilin mRNA and sortilin protein in cultured human
keratinocytes. In our previous study, we also showed that
cutaneous neuropeptides enhance the mature NGF produc-
tion of keratinocytes, which may lead to the survival and
differentiation of the surrounding cells in the human skin
(Dallos et al., 2006a). Our results that keratinocytes express
sortilin and that neuropeptides can decrease the sortilin
expression in keratinocytes, supported our hypotheses, that
(1) the complete proNGF/NGF pathway can operate in
keratinocytes and (2) neuropeptides released from cutaneous
nerves shift the balance to cell proliferation not only by
increasing mature NGF secretion from the keratinocytes, but
also by decreasing their sortilin expression. Nonetheless,
further studies are required to investigate the exact mechan-
ism of the process leading to apoptosis after the induction of
human keratinocytes with proNGF. It seems definitely
worthwhile to study the biological role of the NGF/proNGF
pathway in the skin homeostasis and in different dermato-
logical disorders.
MATERIALS AND METHODS
Cell cultures
Adult epidermal keratinocytes were isolated from breast skin
specimens from healthy female donors (age group 20–40 years)
undergoing plastic surgery. The investigation was approved by the
ethical committee for biomedical trials at the University of Szeged.
Written informed consent was obtained from all donors, and the
study was conducted according to the Principles of the Declaration
of Helsinki. To separate the dermis from the epidermis, overnight
incubation in dispase solution (Grade II, Roche Molecular Biochem-
icals, Indianapolis, IN) was carried out at 4 1C. The epidermis was
then incubated in 0.25% trypsin-EDTA (Sigma, St Louis, MO) for
20minutes at 37 1C. The cells were seeded in keratinocyte serum-
free medium (Gibco BRL, Eggstein, Germany). The medium was
changed every 2 or 3 days. The cultures were maintained at 37 1C,
under a humidified atmosphere, containing 5% CO2.
Cell treatment
On the attainment of approximately 80% confluence after the third
passage, the cultured human keratinocytes were treated with SP,
CGRP, VIP, or GAL at 108 M for 30minutes. For control purposes,
cells were handled as mentioned above, but without neuropeptide
induction. Total RNA was isolated 3, 6 12, and 24hours after
neuropeptide treatment. Cell lysates were collected 24, 48, and
72 hours after neuropeptide treatment.
Reverse transcription-PCR and semiquantitative real-time PCR
Total RNA was isolated from cultures by using the TRIzol reagent
method (Invitrogen, Carlsbad, CA), as described by the manufac-
turer. One microgram of total RNA was reverse-transcribed with the
iScript complementary DNA Synthesis Kit (Bio-Rad Laboratories,
Hercules, CA) according to the manufacturer’s instructions. After
reverse transcription, amplifications were carried out with an iCycler
machine (iCycler IQ Real-Time PCR, Bio-Rad Laboratories). To
detect the presence of sortilin receptor mRNA and of the
endogenous control 18S ribosomal RNA, Human Sortilin TaqMan
Gene Expression Assays (reference numbers Hs00907094_m1 and
Hs03003631_g1) (Applera Hungary, Budapest, Hungary) were used.
After amplification, 15 ml of PCR products was run on 1.5% agarose
gel, stained with ethidium bromide, photographed, and evaluated
with Kodak ID Digital Science software (Scientific Imaging Systems,
New Haven, CT). Each of the PCR reactions was carried out in
duplicate. The amount of complementary DNA was calculated on
the basis of the threshold cycle (CT) value, and was standardized
through the amount of housekeeping gene (18S ribosomal RNA) by
means of the 2DDCT method (Livak and Schmittgen, 2001).
Western blotting
Cultured normal human epidermal keratinocytes and human brain
tissue from a cadaver donor were lysed in 1ml of lysis buffer
containing 62.5mM TRIS (pH 6.8), 5mM EDTA, 1.5% SDS, 5%
b-mercaptoethanol, and 0.2% proteinase inhibitor (Sigma). After
separation by electrophoresis on 10% SDS, polyacrylamide gel
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proteins were transfered to blotting membrane (Bio-Rad Labora-
tories). Rabbit polyclonal antibody against human sortilin (Abcam,
Cambridge, UK) was used at a dilution of 1:50 in 2% skim milk in
Tris-buffered saline (TBS), as primary antibody. Next day, the
membrane was washed in TBS containing 0.5% Tween 20 (TTBS)
and incubated for 75minutes with anti-rabbit IgG-conjugated
alkaline phosphatase (Sigma) at a dilution of 1:2,000. After extensive
washing, the alkaline phosphatase activity was detected with
5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium
(Sigma) as substrate. The specificity of the antibody used against
sortilin was verified by preabsorbing the antibody with a 5-fold
excess concentration of blocking peptide (Abcam) for 4 hours before
addition to the blot. To check on the equal loading of the total
protein in all lanes, blots were developed with a 1:100 dilution of
rabbit polyclonal anti-actin antibody (Sigma). Otherwise, the
conditions were as described above. The results of the western
blotting for sortilin and actin expressions of each sample were filmed
with a Kodak DC290 Zoom Digital Camera (Scientific Imaging
System) and were quantitated densitometrically with Kodak 1D
Digital Science software (Scientific Imaging System).
Immunocytochemistry and immunohistochemistry
Cells were either grown on culture slides or harvested by
trypsinization for cytospin preparation. For cytospins, after centrifu-
gation the cell pellet was resuspended in phosphate-buffered saline
and the cell concentration was set at 1 106 cellsml–1. In all, 100 ml
of cell suspension was placed into plastic tubes, cytocentrifuged
onto glass slides (Cytopro, Wescor, Logan, UT), and then dried
overnight at 25 1C. Cultured slides were fixed in 2% paraformalde-
hyde for 20minutes, and cytospin air-dried slides and frozen
sections from normal human skin were fixed in ice-cold acetone
for 10minutes. Nonspecific binding was blocked with goat serum
(Vectastain ABC Kit, Vector, Burlingame, CA) diluted in TBS-T (Tris-
buffered saline containing 0.1% Triton-X), following the manufac-
turer’s instructions. Slides were incubated with rabbit primary
antibodies specific for human sortilin (Abcam) at a dilution of
1:400 in a staining solution containing 0.5% BSA (Sigma) and goat
serum in TBS-T. Control slides were incubated with rabbit IgG
(NeoMarkers, Fremont, CA) as an isotype control. Endogenous
peroxidase activity was removed by treatment with 0.3% H2O2/
methanol for 20minutes. Slides were then incubated with a
biotinylated secondary antibody for 1 hour at room temperature,
followed by incubation with horseradish peroxidase-conjugated
streptavidin for 1 hour at room temperature and finally peroxidase
activity was detected by using 3,3-amino-9-ethylcarbazole (Sigma)
as a substrate. Slides were counterstained with hematoxylin. The
cells and sections were visualized with a Zeiss Axio Imager
microscope (Carl Zeiss MicroImaging, Thornwood, NY) and photo-
graphed with a PixeLINK digital camera (PixeLINK, Ottawa, ON,
Canada).
Evaluation of keratinocyte apoptosis by DNA fragmentation
and Annexin V assay
Apoptosis in human keratinocytes was detected by using an in situ
apoptosis detection kit (TiterTacs In situ Apoptosis Detection Kit,
R&D Systems, Minneapolis, MN). Briefly, normal human keratino-
cytes were cultured in keratinocyte serum-free medium in 96-well
plates (6,000 cells per well). After 24 hours, the cells were induced
with proNGF (100 ngml–1) as an apoptosis-inducing factor, together
with a combination of proNGF and GAL, VIP, SP, or CGRP. Each of
the neuropeptides was used at a concentration of 108 M. Cells left
without treatment served as control. After 48 hours, the extent of the
apoptosis was determined according to the manufacturer’s instruc-
tions. All reactions were repeated at least six times. Annexin V assay
was performed by using FITC Annexin V and propidium iodide (both
from BD Biosciences, San Jose´) according to the manufacturer’s
instructions. Cells were treated with proNGF and neuropeptides in a
24-well plate (5 104 cells per well) by the above-detailed method;
after a 6-hours incubation the fluorescence of apoptotic cells was
detected with a FACSCalibur and analyzed with CellQuest Software
(BD Biosciences).
Statistical analysis
The data were collected from at least three independent experiments.
Quantitative data are expressed as means±SD. Statistical significance
was determined by using one-way analysis of variance followed by
Dunnett’s and Tukey’s post hoc tests (SPSS, Chicago, IL). Differences
were considered to be statistically significant when Po0.05.
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